Cullinan Therapeutics(CGEM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CGEM Cullinan Therapeutics

休市中 05-17 16:00:00 EDT

23.17

-0.64

-2.69%

盘后23.17

+0.000.00%

19:59 EDT

最高24.27	最低22.75	成交量82.74万
今开23.76	昨收23.81	日振幅6.36%
总市值13.35亿	流通市值7.01亿	总股本5,763万
成交额1,927万	换手率2.74%	流通股本3,024万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CGEM","market":"US","secType":"STK","nameCN":"Cullinan Therapeutics","latestPrice":23.17,"timestamp":1715976000000,"preClose":23.81,"halted":0,"volume":827364,"hourTrading":{"tag":"盘后","latestPrice":23.17,"preClose":23.17,"latestTime":"19:59 EDT","volume":49723,"amount":1152080.83,"timestamp":1715990386892},"delay":0,"floatShares":30241691,"shares":57634234,"eps":-3.145821,"marketStatus":"休市中","marketStatusCode":7,"change":-0.64,"latestTime":"05-17 16:00:00 EDT","open":23.76,"high":24.265,"low":22.75,"amount":19267091.051843997,"amplitude":0.063629,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.145821,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1610082000000,"adjPreClose":23.81,"preHourTrading":{"tag":"盘前","latestPrice":23.81,"preClose":23.81,"latestTime":"08:00 EDT","volume":8,"amount":190.48,"timestamp":1715947200211},"postHourTrading":{"tag":"盘后","latestPrice":23.17,"preClose":23.17,"latestTime":"19:59 EDT","volume":49723,"amount":1152080.83,"timestamp":1715990386892},"volumeRatio":1.1734930513196826},"requestUrl":"/m/hq/s/CGEM","defaultTab":"news","newsList":[{"id":"2435698074","title":"库里南治疗公司（Cullinan Therapeutics Inc）公布截至三月份的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2435698074","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435698074?lang=zh_cn&edition=full","pubTime":"2024-05-16 05:35","pubTimestamp":1715808920,"startTime":"0","endTime":"0","summary":"   * 库里南治疗公司公布了截至3月底的季度调整后每股亏损86美分，高于去年同期的每股收益1.42美元。九位分析师对该季度的平均预期是每股亏损 99 美分。华尔街预期为每股亏损 1.42 美元至-72 美分。* 库里南治疗公司公布的季度每股收益为亏损 86 美分。* 该公司当季亏损 3715 万美元。* Cullinan Therapeutics Inc的股价本季度上涨了54.8%，今年迄今为止上涨了158.9%。华尔街对 Cullinan Therapeutics Inc 的 12 个月目标价中位数为 30.00 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433678155","title":"Cullinan Therapeutics, Inc.盘中异动 快速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433678155","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433678155?lang=zh_cn&edition=full","pubTime":"2024-05-07 23:09","pubTimestamp":1715094563,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日23时09分，Cullinan Therapeutics, Inc.股票出现异动，股价快速拉升5.04%。截至发稿，该股报29.83美元/股，成交量22.7708万股，换手率0.53%，振幅6.69%。Cullinan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Geovax Labs Inc C/Wts 29/09/2025、Armata Pharmaceuticals, Inc.涨幅较大，Clearmind Medicine Inc.、Allarity Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1407.00%、190.09%、176.18%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、珐博进、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为41.69%、41.38%、38.52%。Cullinan Therapeutics, Inc.公司简介：Cullinan Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072309237a588810&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072309237a588810&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433270906","title":"库里南治疗公司  预计每股亏损99美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433270906","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433270906?lang=zh_cn&edition=full","pubTime":"2024-05-07 19:52","pubTimestamp":1715082728,"startTime":"0","endTime":"0","summary":"   * 预计Cullinan Therapeutics Inc    在5月9日公布截至2024年3月31日的业绩时，季度收入将不会有任何变化(预计)。*    * LSEG的分析师对Cullinan Therapeutics Inc的平均预期是每股亏损99美分。* 在过去三个月中，分析师的平均盈利预期上升了约 0.2%。* 华尔街对 Cullinan Therapeutics Inc 的 12 个月目标价中位数为 30.00 美元，高于其上次收盘价 28.40 美元。5月7日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432570612","title":"Cullinan Therapeutics, Inc.盘中异动 早盘股价大涨5.00%报28.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432570612","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432570612?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:47","pubTimestamp":1714571246,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时47分，Cullinan Therapeutics, Inc.股票出现异动，股价大幅上涨5.00%。Cullinan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Cytomx Therapeutics, Inc.、Palisade Bio, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Palisade Bio, Inc.、Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为851.19%、48.44%、21.46%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Promis Neurosciences Inc.、Palisade Bio, Inc.，振幅分别为33.13%、30.95%、26.37%。Cullinan Therapeutics, Inc.公司简介：Cullinan Therapeutics Inc是一家生物制药公司。该信息摘要如下：Cullinan Therapeutics获Stifel首次覆盖，给予买入评级, 目标价40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012147267a57dbe2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012147267a57dbe2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432523577","title":"Cullinan Therapeutics(CGEM.US)获Stifel首次覆盖，给予买入评级, 目标价40.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432523577","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432523577?lang=zh_cn&edition=full","pubTime":"2024-05-01 17:55","pubTimestamp":1714557343,"startTime":"0","endTime":"0","summary":"Cullinan Therapeutics(CGEM.US)获Stifel首次覆盖，给予买入评级, 目标价40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050117554687c73a32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050117554687c73a32&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431639278","title":"Cullinan Therapeutics, Inc.盘中异动 早盘股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431639278","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431639278?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:34","pubTimestamp":1714397665,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时34分，Cullinan Therapeutics, Inc.股票出现异动，股价急速拉升5.22%。截至发稿，该股报26.62美元/股，成交量3.9361万股，换手率0.09%，振幅3.56%。Cullinan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Soleno Therapeutics, Inc.、Zyversa Therapeutics, Inc.、Immunitybio, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为444.86%、23.44%、10.74%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Zyversa Therapeutics, Inc.、Akari Therapeutics Plc，振幅分别为28.57%、17.43%、12.76%。Cullinan Therapeutics, Inc.公司简介：Cullinan Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429213426861ea168&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429213426861ea168&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428665946","title":"Cullinan Oncology, Inc.盘中异动 临近午盘股价大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428665946","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428665946?lang=zh_cn&edition=full","pubTime":"2024-04-19 23:31","pubTimestamp":1713540687,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日23时31分，Cullinan Oncology, Inc.股票出现异动，股价急速跳水5.43%。Cullinan Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Cullinan Oncology, Inc.公司简介：Cullinan Management Inc是一家生物制药公司，专注于开发针对肿瘤的靶向治疗方案，而不偏向特定的治疗模式。消息层面，截至23时31分，《JonesTrading：维持Cullinan Therapeutics评级，由买入调整至买入评级, 目标价由22.00美元调整至26.00美元。》资讯为影响Cullinan Oncology, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192331287921e84d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192331287921e84d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428594241","title":"Cullinan Oncology, Inc.盘中异动 急速上涨5.15%报18.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428594241","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428594241?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:38","pubTimestamp":1713447494,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时38分，Cullinan Oncology, Inc.股票出现波动，股价大幅拉升5.15%。截至发稿，该股报18.80美元/股，成交量1.2826万股，换手率0.03%，振幅3.47%。Cullinan Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Cullinan Oncology, Inc.公司简介：Cullinan Management Inc是一家生物制药公司，专注于开发针对肿瘤的靶向治疗方案，而不偏向特定的治疗模式。消息层面，截至21时38分，《JonesTrading：维持Cullinan Therapeutics评级，由买入调整至买入评级, 目标价由22.00美元调整至26.00美元。》资讯为影响Cullinan Oncology, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041821381579218f73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041821381579218f73&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428356458","title":"JonesTrading：维持Cullinan Therapeutics(CGEM.US)评级，由买入调整至买入评级, 目标价由22.00美元调整至26.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2428356458","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428356458?lang=zh_cn&edition=full","pubTime":"2024-04-18 19:06","pubTimestamp":1713438382,"startTime":"0","endTime":"0","summary":"JonesTrading：维持Cullinan Therapeutics(CGEM.US)评级，由买入调整至买入评级, 目标价由22.00美元调整至26.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181906248b35c945&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181906248b35c945&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428734552","title":"Cullinan Oncology, Inc.盘中异动 股价大涨5.82%报18.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428734552","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428734552?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:32","pubTimestamp":1713360771,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时32分，Cullinan Oncology, Inc.股票出现波动，股价急速上涨5.82%。Cullinan Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。Cullinan Oncology, Inc.公司简介：Cullinan Management Inc是一家生物制药公司。该信息摘要如下：HC Wainwright & Co.：维持Cullinan Oncology评级，由买入调整至买入评级, 目标价由34.00美元调整至29.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041721325187e815df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041721325187e815df&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428360590","title":"美国研究综述-3M、J&J、Nuvalent","url":"https://stock-news.laohu8.com/highlight/detail?id=2428360590","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2428360590?lang=zh_cn&edition=full","pubTime":"2024-04-17 15:48","pubTimestamp":1713340130,"startTime":"0","endTime":"0","summary":"    路透社4月17日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 3M、J&J 和 Nuvalent。要闻              * 3M公司  ：摩根大通将目标价从118美元下调至110美元             * J&J   ：加拿大皇家银行将目标价从181美元下调至175美元             * Nuvalent Inc   ：Jefferies给予买入评级，目标价97美元             * Tractor Supply Co   ：巴克莱将目标价从192美元上调至234美元             * UnitedHealth Group Inc   ：Piper Sandler将目标价从566美元上调至571美元 以下是路透社周三报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2427827404","title":"Cullinan Oncology, Inc.股价上涨19.34% 市值涨1.64亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427827404","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427827404?lang=zh_cn&edition=full","pubTime":"2024-04-16 21:32","pubTimestamp":1713274326,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日21时32分，Cullinan Oncology, Inc.股票出现异动，股价急速拉升19.34%。截至发稿，该股报19.75美元/股，成交量22.2679万股，换手率0.52%，振幅3.63%。Cullinan Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Palisade Bio, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Jaguar Health, Inc.涨幅较大，Palisade Bio, Inc.、Biorestorative Therapies, Inc.、Soligenix, Inc.较为活跃，换手率分别为987.25%、93.57%、29.00%，振幅较大的相关个股有Brainstorm Cell Therapeutics Inc.、Palisade Bio, Inc.、Marinus Pharmaceuticals, Inc.，振幅分别为21.87%、13.46%、13.08%。Cullinan Oncology, Inc.公司简介：Cullinan Management Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162132078b2a987a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162132078b2a987a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426903891","title":"Cullinan Oncology, Inc.盘中异动 股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426903891","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426903891?lang=zh_cn&edition=full","pubTime":"2024-04-09 21:54","pubTimestamp":1712670863,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日21时54分，Cullinan Oncology, Inc.股票出现波动，股价急速拉升5.44%。截至发稿，该股报17.93美元/股，成交量1.9766万股，换手率0.05%，振幅4.50%。Cullinan Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Acrivon Therapeutics, Inc.、Biophytis、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Mymd Pharmaceuticals, Inc.、Biophytis、Acrivon Therapeutics, Inc.较为活跃，换手率分别为366.23%、92.27%、45.29%，振幅较大的相关个股有Biophytis、Mymd Pharmaceuticals, Inc.、Acrivon Therapeutics, Inc.，振幅分别为24.30%、22.18%、20.30%。Cullinan Oncology, Inc.公司简介：Cullinan Management Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409215423791f6b78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409215423791f6b78&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425918631","title":"Cullinan Oncology, Inc.盘中异动 早盘股价大跌5.82%报16.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425918631","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425918631?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:31","pubTimestamp":1712583064,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日21时31分，Cullinan Oncology, Inc.股票出现波动，股价急速下挫5.82%。截至发稿，该股报16.03美元/股，成交量1.0505万股，换手率0.02%，振幅0.06%。Cullinan Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，Longeveron Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大，Allarity Therapeutics, Inc.、Longeveron Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为493.81%、302.24%、51.68%，振幅较大的相关个股有Longeveron Inc.、Cyclerion Therapeutics, Inc.、Cocrystal Pharma, Inc.，振幅分别为10.45%、8.48%、6.90%。Cullinan Oncology, Inc.公司简介：Cullinan Management Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404082131048afebd39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404082131048afebd39&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422487928","title":"Cullinan Oncology, Inc.盘中异动 股价大涨5.01%报17.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422487928","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422487928?lang=zh_cn&edition=full","pubTime":"2024-03-28 03:40","pubTimestamp":1711568403,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日03时40分，Cullinan Oncology, Inc.股票出现波动，股价急速拉升5.01%。截至发稿，该股报17.62美元/股，成交量15.9415万股，换手率0.37%，振幅5.57%。Cullinan Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Ibio, Inc.、Nutriband Inc C/Wts 、Moolec Science Sa C/Wts 涨幅较大，Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Gamida Cell Ltd.较为活跃，换手率分别为4675.46%、1349.42%、89.20%，振幅较大的相关个股有Ibio, Inc.、Nutriband Inc C/Wts 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为150.43%、80.26%、78.00%。Cullinan Oncology, Inc.公司简介：Cullinan Management Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328034004791d52d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328034004791d52d1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421076894","title":"Cullinan Oncology, Inc.盘中异动 股价大涨5.02%报16.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421076894","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421076894?lang=zh_cn&edition=full","pubTime":"2024-03-22 03:24","pubTimestamp":1711049046,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日03时24分，Cullinan Oncology, Inc.股票出现异动，股价急速上涨5.02%。截至发稿，该股报16.31美元/股，成交量16.3432万股，换手率0.38%，振幅3.22%。Cullinan Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。Cullinan Oncology, Inc.公司简介：Cullinan Management Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322032406861e02d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322032406861e02d2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419756901","title":"Cullinan Oncology, Inc.盘中异动 临近午盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419756901","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419756901?lang=zh_cn&edition=full","pubTime":"2024-03-15 23:56","pubTimestamp":1710518219,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日23时56分，Cullinan Oncology, Inc.股票出现异动，股价大幅下跌5.09%。截至发稿，该股报16.05美元/股，成交量11.1094万股，换手率0.26%，振幅5.68%。Cullinan Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，杰龙、Better Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Better Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、知临集团较为活跃，换手率分别为306.31%、78.47%、26.25%，振幅较大的相关个股有Better Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、联拓生物，振幅分别为105.43%、63.00%、49.00%。Cullinan Oncology, Inc.公司简介：Cullinan Management Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315235659791adfc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315235659791adfc8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419606589","title":"库里南肿瘤公司公布截至 12 月的季度业绩 - 盈利摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2419606589","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2419606589?lang=zh_cn&edition=full","pubTime":"2024-03-14 20:51","pubTimestamp":1710420664,"startTime":"0","endTime":"0","summary":"   * 库里南肿瘤公司公布了截至 12 月的季度调整后每股亏损 54 美分，高于去年同期的每股-59 美分。七位分析师对该季度的平均预期是每股亏损 96 美分。华尔街预期为每股-100美分至-91美分。* Cullinan Oncology Inc 报告的本季度每股收益为亏损 54 美分。* Cullinan Oncology Inc 的股价本季度上涨了 66.6%。3月14日 - 预测变化   * 在过去三个月中，分析师的平均盈利预期上升了约 0.2%。华尔街对库利南肿瘤公司 12 个月目标价的中位数为 25.00 美元  本摘要由 LSEG 3 月 14 日中午 12:50  的数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2416640183","title":"BUZZ-库里南肿瘤公司因 FDA 批准血液癌症疗法进行临床试验而崛起","url":"https://stock-news.laohu8.com/highlight/detail?id=2416640183","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2416640183?lang=zh_cn&edition=full","pubTime":"2024-03-01 23:53","pubTimestamp":1709308419,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    3月1日 - ** 药物开发商库里南肿瘤公司  的股票在上午交易中上涨2.1%，至18.85美元** 该公司称 (link)，美国食品和药物管理局（FDA）已批准该公司开始试验其治疗多发性骨髓瘤的实验性癌症疗法。** 多发性骨髓瘤是一种血癌，会影响骨髓中一种叫做浆细胞的白细胞。** CLN-619疗法已获准用于实体瘤的临床试验** 股价在过去 12 个月中上涨了 67","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2415373928","title":"Cullinan Oncology Inc盘中异动 股价大涨5.59%报18.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415373928","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415373928?lang=zh_cn&edition=full","pubTime":"2024-02-28 22:58","pubTimestamp":1709132336,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日22时58分，Cullinan Oncology Inc股票出现异动，股价快速拉升5.59%。截至发稿，该股报18.99美元/股，成交量14.6234万股，换手率0.34%，振幅4.28%。Cullinan Oncology Inc股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，Vivani Medical Inc、Adial Pharmaceuticals Inc、Vtv Therapeutics Inc涨幅较大，Adial Pharmaceuticals Inc、Vivani Medical Inc、Zyversa Therapeutics Inc较为活跃，换手率分别为1056.33%、129.32%、61.88%，振幅较大的相关个股有Vivani Medical Inc、Adial Pharmaceuticals Inc、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为339.60%、171.75%、86.89%。Cullinan Oncology Inc公司简介：Cullinan Management Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022822585687e74627&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022822585687e74627&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cullinantherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.128},{"period":"1month","weight":0.2959},{"period":"3month","weight":0.271},{"period":"6month","weight":1.633},{"period":"1year","weight":1.633},{"period":"ytd","weight":1.2738}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cullinan Therapeutics, Inc.于特拉华州注册成立。该公司是一家生物制药公司，专注于为癌症患者开发具有转化潜力的肿瘤靶向治疗和免疫肿瘤治疗的多样化渠道。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.154237},{"month":2,"riseRate":0.75,"avgChangeRate":0.07927},{"month":3,"riseRate":0.25,"avgChangeRate":-0.102565},{"month":4,"riseRate":0.25,"avgChangeRate":0.06304},{"month":5,"riseRate":0.5,"avgChangeRate":-0.020011},{"month":6,"riseRate":0.666667,"avgChangeRate":0.037358},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.023831},{"month":8,"riseRate":0.333333,"avgChangeRate":0.068606},{"month":9,"riseRate":0,"avgChangeRate":-0.124926},{"month":10,"riseRate":0.666667,"avgChangeRate":0.013464},{"month":11,"riseRate":0,"avgChangeRate":-0.122046},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.016608}],"exchange":"NASDAQ","name":"Cullinan Therapeutics","nameEN":"Cullinan Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cullinan Therapeutics(CGEM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cullinan Therapeutics(CGEM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cullinan Therapeutics,CGEM,Cullinan Therapeutics股票,Cullinan Therapeutics股票老虎,Cullinan Therapeutics股票老虎国际,Cullinan Therapeutics行情,Cullinan Therapeutics股票行情,Cullinan Therapeutics股价,Cullinan Therapeutics股市,Cullinan Therapeutics股票价格,Cullinan Therapeutics股票交易,Cullinan Therapeutics股票购买,Cullinan Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cullinan Therapeutics(CGEM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cullinan Therapeutics(CGEM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}